Anaphylaxis to arthropod bites and stings: Consensus and Controversies

Immunology and Allergy Clinics of North America

Volumn 21, Issue 4, 2001, Pages 635-651

  Yates, A B ^a   Moffitt, J E ^a   De Shazo, R D ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VENOM;

ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTHROPOD; HUMAN; HYMENOPTERA; IMMUNOTHERAPY; INSECT BITE; INSECT STING; PRIORITY JOURNAL; RADIOALLERGOSORBENT TEST; REVIEW; URTICARIA;

EID: 0035209218     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. Protein components of fire ant venom (Solenopsis invicta)
2. Studies of 400 Hymenoptera sting deaths in the United States
3. Identification of acetylcholine, 5-hydroxytryptamine, histamine and a new kinin in hornet venom (V. Crabro)
4. The value of in-hospital insects sting challenge as a criterion for application or omission of venom immunotherapy
5. Fire ant venoms: Comparative analysis of alkaloidal components
6. Tick bite anaphylaxis in Australia
7. Evaluation of commercial imported fire ant extracts by crossed immunoelectrophoresis and radioallergosorbent test
8. The pharmacological effects of Hymenoptera venoms
9. The prevalence of bee sting allergy in an allergic population
10. Insect sting anaphylaxis in patients without detectable serum venom-specific IgE
11. Serum sickness after wasp venom immunotherapy: Clinical and biological study
12. Reaction to the stings of the imported fire ant
13. Dermal hypersensitivity reactions to imported fire ants
14. Prevalence of severe ant-venom allergy in southeastern Australia
15. Successful rush immunotherapy for anaphylaxis to imported fire ants
16. Pharmacological activity of oriental hornet (Vespa orientaIis) venom
17. Lack of reproducibity of a single negative sting challenge response in the assessment of anaphylactic risk in patients with suspected yellow jacket hypersensitivity
18. Imported fire ant immunotherapy: Effectiveness of whole body extracts
19. Coexistent anaphylaxis to diptera and hymenoptera
20. Venom skin tests in insect-allergic and insect non-allergic populations
21. Timing of venom skin tests and IgE determinations after insect sting anaphylaxis
22. Stinging insect vaccines: Patient selection and administration of Hymenoptera venom immunotherapy
23. Insect sting allergy with negative venom skin test responses
24. Discontinuing venom immuno-therapy (VIT): Outcome after five years
25. Natural history of hymenoptera venom sensitivity in adults
26. Epidemiology of insect venom sensitivity
27. The discontinuation of Hymenoptera venom immunotherapy
28. Insect sting allergy: Analysis of a cohort of patients who initiated venom immunotherapy from 1978 to 1986
29. Entomological aspects of insect sting allergy
30. Bee and wasp venoms
31. Seasonal variation in antigens of the imported fire ant Solenoposis invicta
32. In-hospital sting challenge in insect venom-allergic patients after stopping venom immunotherapy
33. Fire ant venom allergy
34. Hymenoptera venom proteins
35. Allergens in bee venom. II: Two new high molecular weight allergic specificities
36. Demonstration of IgE and IgG antibodies against venoms in the blood of victims of fatal sting anaphylaxis
37. Papular urticaria in children
38. Diagnosis of allergy to stinging insects by skin testing with Hymenoptera venoms
39. A controlled trial of immunotherapy in insect hypersensitivity
40. The presence of histamine, 5-hydroxytryptamine and a potent slow contracting substance in wasp venom
41. Imported fire ant hypersensitivity: Studies of human reactions to fire ant venom
42. Expanding habitat of the imported fire ant (Solenopsis invicta): A public health concern?
43. Antigen crossreactivity of venom proteins from hornets, wasps, and yellow jackets
44. 1 and B
45. Safety and efficacy of a 12-week maintenance interval in patients treated with Hymenoptera venom immunotherapy
46. Serum sickness reactions following multiple insect stings
47. Allergic reactions to North African scorpion venom evaluated by skin test and specific IgE
48. Unusual reactions following insect stings: Clinical features and immunological analysis
49. Systemic reactions to stinging ants
50. The Hymenoptera venom study III: Safety of venom immunotherapy
51. Natural history of large local reactions (LLR) to stinging insects
52. Mosquito bite anaphylaxis: Immunotherapy with whole body extracts
53. Management of imported fire ant allergy: Results of a survey
54. Allergic and other reaction to insects
55. Honey bee venom allergy: Results of a sting challenge one year after cessation of successful venom immunotherapy in 86 patients
56. Evaluation of Hymenoptera sting sensitivity with deliberate sting challenges: Inadequacy of present diagnostic methods
57. Harvester ant sensitivity: In vitro and in vivo studies using whole body extracts and venom
58. Stinging insect hypersensitivity: A practice parameter
59. Allergy to stinging insects
60. Duration of venom immunotherapy: Relationship to the severity of symptoms of initial insect sting anaphylaxis
61. Insect stings
62. Insect sting allergy: The dilema of the negative skin test reactor
63. Unusual reactions to insect venoms
64. Venom immunotherapy: 10 Years of experience with administration of single venoms and 50 μg maintenance doses
65. Comparison of the allergenicity and antigenicity of yellow jacket and hornet venoms
66. Studies of coexisting honeybee and vespid venom sensitivity
67. Comparison of the allergenicity and antigenicity of Polistes venom and other vespid venoms
68. Successful immunotherapy for Triatoma protracta-induced anaphylaxis
69. Studies of the natural history of stinging-insect allergy: Long-term follow-up of patients without immunotherapy
70. Starting and stopping venom immunotherapy (VIT) in children with insect sting allergy
71. Epidemiologic study of insect allergy in children. II: Effect of accidental stings in allergic children
72. Prevalence of bee sting allergy in 4,992 Boy Scouts
73. Fractionation of bee venom. I: Preparation and characterization of four antigenic components
74. Allergy to insect stings. IV: Diagnosis by radioallergosorbent test (RAST)
75. Hypersensitivity to fire ant venom
76. Comparison of in vivo and in vitro tests in the diagnosis of imported fire ant sting allergy
77. Anaphylactic reaction after bites by Glossina morsitans (Tsetse fly) in a laboratory worker
78. The natural history of exposure to the imported fire ant (Solenopsis invicta)
79. Sensitivity to the imported fire ant: Successful treatment with immunotherapy
80. Insect-sting challenge in 324 subjects with a previous anaphylactic reaction: Current criteria for insect-venom hypersensitivity do not predict the occurrence and the severity of anaphylaxis
81. Hymenoptera sting challenge of 348 patients: Relation to subsequent field stings
82. A comparison of immunotherapy schedules for injection treatment of ragweed pollen hay fever
83. Multiple hornet stings with features of Reye's syndrome
84. Insect allergy
85. A study of the prevalence and clinical significance of venom-specific IgE